Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 53

1.

Molecular pathogenesis of meningiomas.

Perry A, Gutmann DH, Reifenberger G.

J Neurooncol. 2004 Nov;70(2):183-202. Review.

PMID:
15674477
2.

Pathological classification and molecular genetics of meningiomas.

Mawrin C, Perry A.

J Neurooncol. 2010 Sep;99(3):379-91. doi: 10.1007/s11060-010-0342-2. Epub 2010 Sep 1. Review.

PMID:
20809251
3.

New developments in the pathology of skull base tumors.

Radner H, Katenkamp D, Reifenberger G, Deckert M, Pietsch T, Wiestler OD.

Virchows Arch. 2001 Apr;438(4):321-35. Review.

PMID:
11355165
4.

Pathology and genetics of meningiomas.

Alahmadi H, Croul SE.

Semin Diagn Pathol. 2011 Nov;28(4):314-24. Review.

PMID:
22195409
5.

[The molecular genetics of meningiomas and genotypic/phenotypic correlations].

Dezamis E, Sanson M.

Rev Neurol (Paris). 2003 Sep;159(8-9):727-38. Review. French.

PMID:
13679715
6.

[Meningioma. Classification and grading].

Niedermayer I, Kolles H, Henn W, Zang KD, Steudel WI, Feiden W.

Pathologe. 1997 Sep;18(5):353-8. Review. German.

PMID:
9432670
7.

Histological classification and molecular genetics of meningiomas.

Riemenschneider MJ, Perry A, Reifenberger G.

Lancet Neurol. 2006 Dec;5(12):1045-54. Review. Erratum in: Lancet Neurol. 2007 Feb;6(2):105.

PMID:
17110285
8.

Molecular genetics of meningiomas: from basic research to potential clinical applications.

Simon M, Boström JP, Hartmann C.

Neurosurgery. 2007 May;60(5):787-98; discussion 787-98. Review.

PMID:
17460514
9.

Molecular biological determinants of meningioma progression and aggressive behavior.

Scheck AC, Hendricks W.

Front Biosci (Elite Ed). 2009 Jun 1;1:390-414. Review.

PMID:
19482655
10.

Malignant progression to anaplastic meningioma: Neuropathology, molecular pathology, and experimental models.

Cimino PJ.

Exp Mol Pathol. 2015 Oct;99(2):354-9. doi: 10.1016/j.yexmp.2015.08.007. Epub 2015 Aug 22. Review.

PMID:
26302177
11.

Meningioma pathology, genetics, and biology.

Lamszus K.

J Neuropathol Exp Neurol. 2004 Apr;63(4):275-86. Review.

PMID:
15099018
12.

Intracranial meningiomas of atypical (WHO grade II) histology.

Rogers L, Gilbert M, Vogelbaum MA.

J Neurooncol. 2010 Sep;99(3):393-405. doi: 10.1007/s11060-010-0343-1. Epub 2010 Aug 26. Review.

PMID:
20740303
13.

The molecular genetics and tumor pathogenesis of meningiomas and the future directions of meningioma treatments.

Choy W, Kim W, Nagasawa D, Stramotas S, Yew A, Gopen Q, Parsa AT, Yang I.

Neurosurg Focus. 2011 May;30(5):E6. doi: 10.3171/2011.2.FOCUS1116. Review.

PMID:
21529177
14.

The role of folate metabolism-related gene polymorphisms in the development of meningiomas.

Drakos SS, Anifantaki F, Zarros A, Liapi C.

Cancer Genomics Proteomics. 2010 Mar-Apr;7(2):105-9. Review.

PMID:
20335525
15.

Molecular genetics of meningiomas.

Ragel BT, Jensen RL.

Neurosurg Focus. 2005 Nov 15;19(5):E9. Review.

PMID:
16398473
16.

[MOLECULAR PATHOLOGY OF MENINGIOMAS].

Murnyák B, Csonka T, Hortobágyi T.

Ideggyogy Sz. 2015 Sep 30;68(9-10):292-300. Review. Hungarian.

PMID:
26665490
17.

[Meningiomas: anatomical pathology and molecular biology].

Bekiashev AKh, Korshunov AG, Cherekaev VA.

Arkh Patol. 2007 Sep-Oct;69(5):48-54. Review. Russian.

PMID:
18074823
18.

[Meningiomas: prognostic relevance of histopathologic and genetic markers].

Kros JM, Wolbers JG.

Ned Tijdschr Geneeskd. 2001 Nov 10;145(45):2160-5. Review. Dutch.

PMID:
11727613
19.

Genetic/molecular alterations of meningiomas and the signaling pathways targeted.

Domingues P, González-Tablas M, Otero Á, Pascual D, Ruiz L, Miranda D, Sousa P, Gonçalves JM, Lopes MC, Orfao A, Tabernero MD.

Oncotarget. 2015 May 10;6(13):10671-88. Review.

20.

Meningioma: an update.

Lusis E, Gutmann DH.

Curr Opin Neurol. 2004 Dec;17(6):687-92. Review.

PMID:
15542977

Supplemental Content

Support Center